Sort
8,912 grants matching “sars cov 2”
The Role of alternative mRNA polyadenylation in SARS-CoV-2 replication & the host response
$247,500Claire L Moore · Tufts University Boston · R21 · FY2023 · AI
STTR Phase I: The Coupling of COVID-19 Respiratory Droplet Adsorption and Photocatalysis through Metal Organic Frameworks
$247,457Ray O Ozdemir · Framergy, Inc. · · FY2021 · TIP
Potential role of skin in SARS-CoV-2 infection
$247,411Irina V Budunova · Northwestern University At Chicago · R21 · FY2023 · AI
IVOS Medical: Intubation, optimized.
$247,334Waylan Wong · Ivos Medical, Inc. · R43 · FY2022 · HL
Pediatric COVID-19 Severity Dashboard During Delta Variant Circulation
$247,165Tellen Bennett · University Of Colorado Denver · R01 · FY2021 · HD
Antagonism of Coronavirus Spike Proteins by Cellular Host Factors
$247,114Eric Freed · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Emerging infections: surveillance, epidemiology and pathogenesis
$247,061David Wang · Washington University · U01 · FY2022 · AI
Respiratory morbidity during the pandemic time in individuals with Down syndrome
$246,832Pingsheng Wu · Vanderbilt University Medical Center · R01 · FY2024 · AI
The "olfactosome" as a biomolecular condensate
$246,750Stavros Lomvardas · Columbia University Health Sciences · R21 · FY2022 · DA
Changes in the public health burden of tobacco use during the COVID-19 pandemic: the C4R Study
$246,750Pallavi P Balte · Columbia University Health Sciences · R21 · FY2022 · HL
Using wastewater surveillance data to study SARS-CoV-2 dynamics and predict COVID-19 outcomes
$246,750Wan Yang · Columbia University Health Sciences · R21 · FY2023 · AI
Identifying and evaluating prevention strategies for COVID-19 in correctional facilities
$246,736Margaret Lind · Boston University Medical Campus · R00 · FY2024 · AI
SBIR Phase I: A Novel SARS-CoV-2 Virus-Like Particle Optimized to Deliver shRNA Therapeutics to Prevent and Treat Infection (COVID-19)
$246,731Michelle Ngai · Nanored Llc · · FY2021 · TIP
Immunologic Studies Associated with COVID-19
$246,576Susan Moir · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Understand the molecular mechanism of age-associated decline in antiviral CD8 T cell immunity
$246,000Tuoqi Wu · Ut Southwestern Medical Center · R21 · FY2024 · AG
Mitoquinone/mitoquinol mesylate as oral and safe Postexposure Prophylaxis for Covid-19
$246,000Theodoros Kelesidis · Ut Southwestern Medical Center · R21 · FY2023 · AI
Pre-Analytic Factors affecting Molecular tests for Congenital Syphilis
$246,000Jeffrey Sorelle · Ut Southwestern Medical Center · R21 · FY2024 · AI
Investigating the molecular mechanisms of membrane remodeling by coronaviruses
$246,000Michael Joseph Ragusa · Dartmouth College · UH2 · FY2024 · AI
Assembly and release of the SARS coronavirus
$246,000Carolyn E Machamer · Johns Hopkins University · R21 · FY2007 · AI
Identifying existing, FDA-approved drugs with clinically protective effects against coronavirus disease 2019 using a big data approach
$245,839Josh Lambert · University Of Cincinnati · R21 · FY2021 · LM
A muco-penetrating biomaterial-based subunit vaccine for programming protective immune responses to SARS-CoV-2
$245,625David Scott Wilson · Johns Hopkins University · R21 · FY2023 · EB
Profiling the immune response to convalescent plasma therapy during severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection
$245,625Jay H. Bream · Johns Hopkins University · R21 · FY2023 · AI
The first polymeric opioid conjugate vaccine
$245,625David Scott Wilson · Johns Hopkins University · R21 · FY2022 · DA
mRNA vaccine responses in PLWH
$245,625Joel N Blankson · Johns Hopkins University · R21 · FY2022 · AI
Immunogen Design for SARS-CoV-2
$245,592Peter D Kwong · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI